Forma Therapeutics to Participate in Upcoming Investor Conferences
04 November 2020 - 11:05PM
Business Wire
Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a
clinical-stage biopharmaceutical company focused on rare
hematologic diseases and cancers, today announced that company
management will participate in three upcoming investor
conferences.
- The Credit Suisse 29th Annual Healthcare Conference taking
place November 9-12. Forma will present via webcast on Wednesday,
November 11 at 2:45 p.m. Eastern Standard Time (EST).
- The Jefferies 2020 Virtual London Healthcare Conference taking
place November 17-19. Forma will present via webcast on Wednesday,
November 18 at 7:55 p.m. Greenwich Mean Time (GMT).
- The Virtual SVB Leerink Oncology 1X1 Day taking place November
19. Forma will participate virtually in one-on-one meetings during
this event on Thursday, November 19.
A live webcast of the presentations at the Credit Suisse and
Jefferies conferences will be available in the “News &
Investors” section of Forma’s website at
www.formatherapeutics.com.
About Forma Therapeutics
Forma Therapeutics is a clinical-stage biopharmaceutical company
focused on the research, development and commercialization of novel
therapeutics to transform the lives of patients with rare
hematologic diseases and cancers. Our R&D engine combines deep
biology insight, chemistry expertise and clinical development
capabilities to create drug candidates with differentiated
mechanisms of action focused on indications with high unmet need.
Our work has generated a broad proprietary portfolio of programs
with the potential to provide profound patient benefit. For more
information, please visit www.FormaTherapeutics.com or follow us on
Twitter @FORMAInc and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201104005050/en/
Media Contact: Kari Watson, +1 781-235-3060 MacDougall
kwatson@macbiocom.com
Investor Contacts: Mario Corso, +1 781-366-5726 Forma
Therapeutics, Inc. mcorso@formatherapeutics.com
Stephanie Ascher, +1 212-362-1200 Stern Investor Relations
stephanie.ascher@sternir.com
Forma Therapeutics (NASDAQ:FMTX)
Historical Stock Chart
From Jul 2024 to Aug 2024
Forma Therapeutics (NASDAQ:FMTX)
Historical Stock Chart
From Aug 2023 to Aug 2024
Real-Time news about Forma Therapeutics Holdings Inc (NASDAQ): 0 recent articles
More Forma Therapeutics Holdings Inc News Articles